A Hit and a Miss for Liquid Biopsy to Guide Adjuvant Cancer Therapy

By News Health
1 month Ago

(MedPage Today) — BERLIN — Survival in high-risk bladder cancer improved significantly with use of circulating tumor (ct)DNA to guide adjuvant treatment in patients who tested positive after surgery, the randomized, placebo-controlled IMvigor011…

Source link : https://www.medpagetoday.com/meetingcoverage/esmo/118072

Author :

Publish date : 2025-10-21 21:36:00

Copyright for syndicated content belongs to the linked Source.

Categories: Health News

Related Content

Baby formula milk can be bought with supermarket loyalty points

Tool Helps Predict Cancers in Patients With Dermatomyositis

Radiology Is Ill-Prepared to Weather the Storms of Climate Change

Chances Dwindling for Renewal of ACA Subsidies, Risking Premium Spikes for Millions

Sleepy Donald? 'Full House' Star Has Cancer; $10M COVID Vaccine Settlement

Forming moon may have taken three big impacts early in Earth’s history